Self-managed medication abortion trajectories: results from a prospective observational study in Argentina, Nigeria and Southeast Asia.

Autor:	Pleasants EA; School of Public Health, University of California Berkeley, Berkeley, California, USA., Jayaweera RT; Ibis Reproductive Health, Oakland, California, USA., Egwuatu I; Generation Initiative for Women and Youth, Lagos, Nigeria., Nmezi S; Generation Initiative for Women and Youth, Lagos, Nigeria., Kristianingrum IA; Samsara, Java, Indonesia., Zurbriggen R; La Revuelta Colectiva Feminista, Neuquén, Argentina., Grosso B; La Revuelta Colectiva Feminista, Neuquén, Argentina., Bercu C; Ibis Reproductive Health, Oakland, California, USA., Motana R; Ibis Reproductive Health, Johannesburg, Gauteng, South Africa., Gerdts C; Ibis Reproductive Health, Oakland, California, USA., Moseson H; Ibis Reproductive Health, Oakland, California, USA hmoseson@ibisreproductivehealth.org.
Jazyk:	angličtina
Zdroj:	BMJ sexual & reproductive health [BMJ Sex Reprod Health] 2024 Jul 12; Vol. 50 (3), pp. 155-164. Date of Electronic Publication: 2024 Jul 12.
DOI:	10.1136/bmjsrh-2023-201979
Abstrakt:	Objectives: Time is a crucial factor in abortion-seeking because options for care change with pregnancy duration, and most people prefer to access abortion care early in pregnancy. We aimed to collect data on the timing of steps in accompanied self-managed abortion-seeking experiences in legally restrictive settings. Methods: In this prospective, observational, cohort study we recruited callers from three abortion accompaniment groups in Argentina, Nigeria and a country in Southeast Asia. Participants completed a baseline survey before starting a self-managed medication abortion (SMA) and two follow-up surveys (approximately 1 and 3 weeks after taking medication). Primary outcomes of interest included: (1) time from abortion decision to contacting the hotline, (2) time from contacting the hotline to obtaining pills and (3) time from obtaining pills to taking the first dose. We explored relationships between participant characteristics and each of these outcomes and evaluated differences in overall abortion time using survival analyses. Results: Between July 31, 2019 and October 01, 2020 we enrolled 1352 eligible callers; 1148 provided data for this analysis. After deciding to have an abortion, participants took 12.2 days on average (95% CI: 11.6, 12.9) to start medications for abortion. On average, participants at later pregnancy durations progressed through the SMA process more quickly (<4 weeks: 20.9 days, 4 weeks: 11 days, 5-6 weeks: 10.1 days, 7-9 weeks, 10.4 days, 10+ weeks: 9.1 days; p<0.001). Conclusions: Overall, participants accessed accompaniment group support and started abortion regimens quickly and at relatively early pregnancy durations. SMA with accompaniment provided a time-efficient route for obtaining abortions. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu